Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2013
11/05/2013US8575307 Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
11/05/2013US8575093 Composition and method for treating Streptococcus pneumoniae infection
11/05/2013US8574925 Fluorescence analysis method using fluorescent-activating antibodies
11/05/2013US8574830 Binding protein and epitope-blocking ELISA for the universal detection of H5-subtype influenza viruses
11/05/2013US8574590 Lipoparticles comprising proteins, methods of making, and using the same
11/05/2013US8574581 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
11/05/2013US8574580 Monoclonal antibodies that recognize neurospheres or neural progenitor cells
11/05/2013US8574579 Anti-IL-23 antibodies
11/05/2013US8574577 VEGF antibodies comprising modular recognition domains
11/05/2013US8574575 RS7 antibodies
11/05/2013US8574573 Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders
11/05/2013CA2690395C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
11/05/2013CA2507811C Process for the determination of the primary structure of the messenger rna coding for the human recombinant endooligopeptidase a (heopa) [af217798]
11/05/2013CA2505849C Novel tricistronic vectors and uses therefor
11/05/2013CA2398979C Novel bee venom polypeptides and methods of use thereof
11/05/2013CA2394015C Tweak receptor
11/05/2013CA2328403C Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
10/2013
10/31/2013WO2013163631A2 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
10/31/2013WO2013163630A1 Modified antibody regions and uses thereof
10/31/2013WO2013163519A1 Anti-cd22 antibodies
10/31/2013WO2013163427A1 Antibodies to treat hiv-1 infection
10/31/2013WO2013163377A1 Human cd30 ligand antigen binding proteins
10/31/2013WO2013163297A1 Modified glycoproteins
10/31/2013WO2013162748A1 Anti-tumor endothelial marker-1 (tem1) antibody variants and uses thereof
10/31/2013WO2013161814A1 Anti-human cd69 antibody, and use thereof for medical purposes
10/31/2013WO2013160879A1 Anti-robo4-antibody
10/31/2013WO2013160676A1 Antibodies against cd106 (vcam-1)
10/31/2013WO2013160498A1 Human anti-her2 monoclonal antibody
10/31/2013WO2013160396A1 Combination of cd37 antibodies with bendamustine
10/31/2013WO2013160359A1 Anti-pdgf-c antibodies
10/31/2013WO2013127373A3 Recombinant antibodies having dual specificity for gangliosides and use thereof
10/31/2013WO2013119960A3 Anti-cd324 monoclonal antibodies and uses thereof
10/31/2013WO2013114240A3 Method for obtaining glycoprotein composition
10/31/2013WO2013101993A3 Dual variable domain immunoglobulins against receptors
10/31/2013WO2003044159A9 Zinc finger proteins, polynucleotides encoding same and antibodies thereto
10/31/2013WO2003023014A9 Human ion channels
10/31/2013WO2002098346A3 Method and pharmaceutical composition for the treatment of multiple sclerosis
10/31/2013WO2002078598A3 Peptides and antibodies to muc 1 proteins
10/31/2013WO2002077260A9 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/31/2013WO2002077001A9 Novel receptors
10/31/2013US20130291136 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
10/31/2013US20130291134 Humanized transgenic mouse model
10/31/2013US20130289250 Antibody against the cfr-1r
10/31/2013US20130289248 Anticoagulant antidotes
10/31/2013US20130289246 Influenza virus antibodies and immunogens and uses therefor
10/31/2013US20130289237 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions
10/31/2013US20130289022 Tetrameric alpha-synuclein and use thereof
10/31/2013US20130288927 Fusion Proteins to Facilitate Selection of Cells Infected with Specific Immunoglobulin Gene Recombinant Vaccinia Virus
10/31/2013US20130288387 Anti-hla monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin
10/31/2013US20130288363 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same
10/31/2013US20130288333 Protein complex using an immunoglobulin fragment and method for the preparation thereof
10/31/2013US20130288305 Anti-fgfr2 antibodies
10/31/2013US20130288304 Polynucleotides encoding antibodies that bind both il-17a and il-17f
10/31/2013US20130288303 Humanized c-Kit Antibody
10/31/2013US20130288302 Humanized anti-beta7 antagonists and uses therefor
10/31/2013US20130288279 Specific a1at monoclonal antibodies for detection of endometriosis
10/31/2013US20130288277 Immunoassay of cofilin 1 protein
10/31/2013US20130288267 Detection of a polypeptide dimer by a bivalent binding agent
10/31/2013US20130288266 Detection of a posttranslationally modified polypeptide by a bi-valent binding agent
10/31/2013US20130287838 Vaccine engineering
10/31/2013US20130287802 Targeted/immunomodulatory fusion proteins and methods for making same
10/31/2013US20130287799 Abeta conformer selective anti-abeta globulomer monoclonal antibodies
10/31/2013US20130287798 Uses of monoclonial antibody 8h9
10/31/2013US20130287796 Sp35 Antibodies and Uses Thereof
10/31/2013US20130287795 Anti-ephrin-b2 antibody and use thereof
10/31/2013US20130287787 Monoclonal antibodies that react with the capsule of bacillus anthracis
10/31/2013US20130287785 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
10/31/2013US20130287784 Compositions Targeting the Soluble Extracellular Domain of E-Cadherin and Related Methods for Cancer Therapy
10/31/2013US20130287783 Anti-gcc antibody molecules and methods for use of same
10/31/2013US20130287782 Enterococcus antigens
10/31/2013US20130287781 Immunoglobulins
10/31/2013US20130287779 Humanized anti-egfl7 antibodies and methods using same
10/31/2013US20130287777 ST2L Antagonists and Methods of Use
10/31/2013US20130287773 Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS
10/31/2013US20130287771 Isolation and Purification of Anti-IL-13 Antibodies Using Protein A Affinity Chromatography
10/31/2013US20130287770 Human anti-kir anitbodies
10/31/2013US20130287766 Antibodies and methods for making and using them
10/31/2013US20130287762 Neutralizing antibodies against gdf-8 and uses therefor
10/31/2013US20130287755 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-trna synthetases
10/31/2013US20130287738 Disease-associated protein
10/31/2013US20130287693 NOGO Receptor Binding Protein
10/31/2013US20130287691 Anti-gd2 antibodies and methods and uses related thereto
10/31/2013US20130287684 Anti-her3 antibodies and compositions
10/31/2013US20130287683 Acute Leukemia And Lymphoblastic Lymphoma-Specific CD43 Epitope and Use Thereof
10/30/2013EP2657704A1 Method for detecting all Haemophilus influenzae
10/30/2013EP2657334A1 Efficient method for displaying protein multimer
10/30/2013EP2657333A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof
10/30/2013EP2657255A1 Aminated complex-type sugar chain derivatives and process for the production thereof
10/30/2013EP2657253A2 Anti-CD79b antibodies and immunoconjugates and methods of use
10/30/2013EP2655646A2 Targeted perhydrolases
10/30/2013EP2655624A2 Linker peptides and polypeptides comprising same
10/30/2013EP2655419A1 Anti-pcsk9 antibodies and methods of use
10/30/2013EP2655418A2 Anti-mesothelin antibodies and immunoconjugates
10/30/2013EP2655417A2 Il-1 -alpha and -beta bispecific dual variable domain immunoglobulins and their use
10/30/2013EP2655416A1 Anti-il-18 antibodies and their uses
10/30/2013EP2655415A2 Tri-variable domain binding proteins and uses thereof
10/30/2013EP2655414A1 Binding agent
10/30/2013EP2655413A1 Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
10/30/2013EP2655412A1 Isoform enriched antibody preparation and method for obtaining it
10/30/2013EP2655411A1 Fibronectin based scaffold domain proteins that bind il-23
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 1494